BioCentury
ARTICLE | Company News

Management tracks

May 10, 2017 11:44 PM UTC

RNA company Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) announced several additions. The biotech named Alan Eisenberg VP of global public policy and government relations; Theresa Heggie SVP and head of Europe and Canada; Peter Smith SVP of early development; and Manmeet Soni CFO. Eisenberg was VP of federal government relations at Celgene Corp. (NASDAQ:CELG). Heggie was chief marketing and strategy officer at The British United Provident Association, and Smith was head of non-clinical R&D at Moderna Therapeutics Inc. (Cambridge, Mass.). Soni was CFO and treasurer at Ariad Pharmaceuticals Inc., which Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) acquired.

Cancer company Aravive Biologics Inc. (Houston, Texas) named Stephen Eck president and CEO. He was VP of oncology medical sciences at the Astellas Pharma Global Development Inc. unit of Astellas Pharma Inc. (Tokyo:4503). ...